Pramipexole for Depression

The role of dopamine in the pathophysiology of depression

Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · see citing works

Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder

Berk, M., Dodd, S., Kauer‐Sant’Anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., & Norman, T. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01058.x · Cited by 396 · see citing works

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

Zarate, C. A., Payne, J. L., Singh, J. B., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 343 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Compulsive eating and weight gain related to dopamine agonist use

Nirenberg, M. J., & Waters, C. (2005) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 261 · see citing works

Nonmotor manifestations of Parkinson's disease

Simuni, T., & Sethi, K. D. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 236 · see citing works

Invited review: the evolution of antidepressant mechanisms

Slattery, D. A., Hudson, A. L., & Nutt, D. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00195.x · Cited by 185 · see citing works

The dopamine D receptor and drug dependence: Effects on reward or beyond?

Foll, B. L., Goldberg, S. R., & Sokoloff, P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.022 · Cited by 183 · see citing works

Dopamine D2-Like Receptors and the Antidepressant Response

Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 159 · see citing works

Non-motor extranigral signs and symptoms in Parkinson's disease

Wolters, E. C. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70770-9 · Cited by 134 · see citing works

Pramipexole in Psychiatry

Aiken, C. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0810 · Cited by 129 · see citing works

Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects

Foll, B. L., Sokoloff, P., Stark, H., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300622 · Cited by 97 · see citing works

Ropinirole in treatment-resistant depression: a 16-week pilot study

Cassano, P., Lattanzi, L., Fava, M., Navari, S., Battistini, G., Abelli, M., & Cassano, G. B. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000612 · Cited by 73 · see citing works

Aripiprazole Augmentation in Treatment-Resistant Depression

Barbee, J. G., Conrad, E. J., & Jamhour, N. J. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490521954 · Cited by 54 · see citing works

Antidepressant drug development: Focus on triple monoamine reuptake inhibition

Lane, R. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553252 · Cited by 41 · see citing works

Evaluation of basal ganglia, brainstem raphe and ventricles in bipolar disorder by transcranial sonography

Krogias, C., Hoffmann, K., Eyding, J., Scheele, D., Norra, C., Gold, R., Juckel, G., & Assion, H. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.002 · Cited by 36 · see citing works

Binding of Pramipexole to Extrastriatal Dopamine D2/D3 Receptors in the Human Brain: A Positron Emission Tomography Study Using 11C-FLB 457

Ishibashi, K., Ishii, K., Oda, K., Mizusawa, H., & Ishiwata, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017723 · Cited by 32 · see citing works

Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis

Tundo, A., Betrò, S., de Filippis, R., Marchetti, F., Nacca, D., Necci, R., & Iommi, M. (2023) · Life · doi:10.3390/life13041043 · Cited by 30 · see citing works

The role of dopaminergic agents in improving quality of life in major depressive disorder

IsHak, W. W., Davis, M. C., Jeffrey, J. K., Balayan, K., Pechnick, R. N., Bagot, K. S., & Rapaport, M. H. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0076-z · Cited by 25 · see citing works

The Cerebrovascular Model of Depression in Late Life

Lyness, J. M. (2002) · CNS Spectrums · doi:10.1017/s1092852900008695 · Cited by 15 · see citing works

Recognition and management of Parkinson’s disease during the premotor (prodromal) phase

Truong, D. D., & Wolters, E. C. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.50 · Cited by 14 · see citing works

[Antidepressant effects of dopamine agonists. Experimental and clinical findings].

Lemke, M. R. (2007) · PubMed · doi:10.1007/s00115-006-2104-0 · Cited by 13 · see citing works

Ropinirole Augmentation for Depression

Gershon, A. A., Amiaz, R., David, H. S., & Grunhaus, L. J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000984 · Cited by 11 · see citing works

Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice

Lehr, E. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1199-7 · Cited by 11 · see citing works

Pramipexole augmentation in treatment-resistant major depressive disorder

Pae, C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.864556 · Cited by 6 · see citing works

Pramipexole in unipolar and bipolar depression

Whiskey, E., & Taylor, D. M. (2004) · Psychiatric Bulletin · doi:10.1192/pb.28.12.438 · Cited by 6 · see citing works

Pramipexole-Induced Peripheral Edema in a Patient With Bipolar Depression

Sato, S., Hori, T., Tsutsumi, K., & Asada, T. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.4.jnpe20 · Cited by 3 · see citing works

Ropinirole in Bipolar Disorder: Rate of Manic Switching and Change in Disease Severity

Capote, H. A., Rainka, M. M., Westphal, E. S., Beecher, J., & Gengo, F. M. (2017) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12205 · Cited by 3 · see citing works

Neuroprotection in Bipolar Depression

Aiken, C. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_15 · Cited by 2 · see citing works

10.5 The Role of Dopamine in the Pathophysiology and Treatment of Major Depressive Disorder

Dunlop, B. W., & Nemeroff, C. B. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0040 · Cited by 2 · see citing works

Motion und Emotion: Morbus Parkinson und Depression

Lemke, M. R. (2005) · Springer eBooks · doi:10.1007/3-540-26841-3_8 · Cited by 1 · see citing works

Euforia secundaria a pramipexol

Gómez, T. L., Díaz, A., Sío, S. B., & Martínez, M. J. L. (2003)

The Pharmacological Basis for Parkinson's Disease Treatment

(2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.001

Oral dopamine agonists in the management of Parkinson's disease

Pagonabarraga, J., Marín‐Lahoz, J., & Kulisevsky, J. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.005

Targeting the Dopamine D 3 Receptor for Treatment of Nicotine Dependence

Foll, B. L., & Goldberg, S. R. (2006) · CRC Press eBooks · doi:10.1201/9781420005431.ch14

Dopaminagonisten als Antidepressiva. Experimentelle und klinische Befunde

Lemke, M. R. (2007) · Der Nervenarzt

Dopaminagonisten

Lemke, M. R. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_25

Behavioral Pharmacology of Dopamine D2 and D3 Receptor Agonists and Antagonists in Rats.

Collins, G. T. (2008) · Deep Blue (University of Michigan)

Pramipexole in Refractory Bipolar Depression

Goldberg, J. F., Frye, M. A., & Dunn, R. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.798 · Cited by 46 · see citing works

Pramipexole Acts as Antidepressant in PD

LONDON, S. (2009) · Clinical Psychiatry News · doi:10.1016/s0270-6644(09)70329-7

Pramipexole for Parkinson's disease.

Rm, T., & Rw, F. (1998) · PubMed · Cited by 1 · see citing works

Pramipexole in the treatment of Parkinson's disease

(1999) · PubMed

Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression

FAWCETT, J. A., Rush, A. J., Vukelich, J., Diaz, S. H., Dunklee, L., Romo, P. E., Yarns, B. C., & Escalona, R. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060788 · Cited by 94 · see citing works